Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-100
Closed -$20K 104
2024
Q1
$20K Hold
100
0.01% 101
2023
Q4
$17K Hold
100
0.01% 100
2023
Q3
$16K Hold
100
0.01% 97
2023
Q2
$16K Hold
100
0.01% 98
2023
Q1
$15K Hold
100
0.01% 98
2022
Q4
$13K Buy
+100
New +$13.6K 0.01% 97
2022
Q2
Sell
-100
Closed -$15K 104
2022
Q1
$15K Buy
+100
New +$12.3K 0.01% 103

Other funds holding NUE

Lipe & Dalton's NUE Position: Q2 2024 in Review

Lipe & Dalton sold out of Nucor (NUE) in Q2 2024, closing a stake of 100 shares — an estimated $20K sold.

Lipe & Dalton first reported a position in NUE in Q1 2022 and held it in 7 quarters. The position peaked at $20K in Q1 2024. 1,232 funds tracked by Wall St. Rank hold NUE as of Q2 2024.

  • Lipe & Dalton reported no remaining Nucor position as of Q2 2024 after selling out during the quarter.
  • Lipe & Dalton sold 100 Nucor shares in Q2 2024, an estimated $20K.
  • Lipe & Dalton first reported a position in Nucor in Q1 2022 and held it in 7 quarters.
  • Lipe & Dalton's Nucor position peaked at $20K in Q1 2024.
  • 1,232 funds tracked by Wall St. Rank held Nucor as of Q2 2024.

Based on Lipe & Dalton's 13F filing for Q2 2024, filed 2 Aug 2024.